Skip to main content
Clinical Trials/NCT02070666
NCT02070666
Terminated
Not Applicable

Preventive Strategies in Acute Respiratory Distress Syndrome

Corporacion Parc Tauli1 site in 1 country98 target enrollmentMay 2014
ConditionsARDS

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ARDS
Sponsor
Corporacion Parc Tauli
Enrollment
98
Locations
1
Primary Endpoint
ARDS development
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

The investigators hypothesis is that patients at risk of ARDS, detected by LIPS (Lung Injury Prediction Score), under mechanical ventilation could benefit from a protective ventilatory strategy (used in ARDS treatment) in order to avoid or decrease the ARDS development. This would lead to a decrease in incidence, mortality and health care costs associated to this syndrome.

This study will help to confirm the current evidence about low tidal volumes, evaluating adverse events of this strategy.

Detailed Description

The main objective is to evaluate the effect of a protective ventilatory strategy by using lower tidal volumes compared to the use of traditionally volumes in ARDS development.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
June 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Corporacion Parc Tauli
Responsible Party
Principal Investigator
Principal Investigator

Antonio Artigas Raventós

Director of Critical Care Arrea

Corporacion Parc Tauli

Eligibility Criteria

Inclusion Criteria

  • Patients within 12 hours after start of invasive mechanical ventilation (MV) and admitted to participating ICU (it is recommended an inclusion as soon as possible during the first 3 hours).
  • LIPS \> 4 points.
  • Absence of mild, moderate and severe ARDS criteria (Berlin definition).
  • Older than 18 year-old.
  • Signed informed consent

Exclusion Criteria

  • Bilateral pulmonary infiltrates in chest X-ray at admission.
  • Mechanical ventilation \> 12 hours.
  • Previous pneumonectomy or lobectomy.
  • Severe cranial trauma (Glasgow Coma Scale\<9) or cranial hypertension.
  • Severe chronic pulmonary disease (GOLD IV).
  • Admission from other hospital under MV.
  • Limitation of therapeutic effort.
  • Pregnancy.
  • Acute pulmonary embolism.
  • Participation in other interventional trials.

Outcomes

Primary Outcomes

ARDS development

Time Frame: 7 days

To determine the effect of a protective mechanical ventilation strategy using lower tidal volumes as compared to mechanical ventilation using traditionally-sized tidal volumes on development of ARDS.

Secondary Outcomes

  • Mortality(90 days)
  • Ventilator-free days(28 days after admission)
  • Pneumonia(7 days)
  • Dead space(7 days)
  • Length of stay(participants will be followed for the duration of ICU (Intensive Care Unit) and hospital stay, an expected average of 4 weeks)
  • Atelectasis(7 days)

Study Sites (1)

Loading locations...

Similar Trials